28 min
Nik Sharma & Mo Alomari: The Future of Tech Bio: | Episode 23 Nothing Ventured
-
- Entrepreneurship
In this episode of Nothing Ventured, we delve into the world of tech bio
with co-founders Nik Sharma and Mo Alomari from BioCortex. They discuss
reflecting biology in silico, NASA-inspired strategies, and the
importance of trust in co-founder relationships. Learn how BioCortex is
revolutionizing therapeutic development with insights backed by Hoxton
and Sofinova. Tune in for a deep dive into the intersection of
technology and biotech with these innovative minds.
🕒 Time stamps -
01:01 - Introducing Guests Nick Sharma and Mo Al-Omari
01:55 - Emulation vs. Simulation in Tech Bio
02:16 - BioCortex: A Tech Bio Company Overview
02:27 - Founders' Backgrounds and Expertise
03:09 - BioCortex's Vision and Technology
03:33 - Personalizing Medication Efficacy with BioCortex
04:15 - Broader Applications of BioCortex Technology
04:31 - Carbon Knowledge and Carbon Mirror Technologies
05:03 - Emulation in Aerospace Applied to Biology
05:38 - Conceptualizing Human Biology for Drug Interaction
06:25 - Understanding Emulation and Simulation
07:04 - The Role of Bacteria in Drug Efficacy
07:34 - The Distinction Between Emulation and Simulation
08:34 - NASA's Use of Emulation
09:10 - The Importance of Understanding Mechanisms in Medicine
09:43 - The Reality of Drug Response Rates
10:21 - BioCortex's Approach to AI and Emulation
11:01 - The Co-Founders' Meeting and Collaboration
11:29 - The Genesis of BioCortex
12:00 - Addressing Motor Neurone Disease Communication
13:02 - The Evolution of Nick and Mo's Partnership
13:38 - The Challenge of Modeling Bacteria
14:02 - The Solution to Modeling Complex Biological Systems
14:58 - The Importance of Trust in Co-Founder Relationships
16:01 - The Dynamics of Co-Founder and VC Relationships
16:53 - Defining Tech Bio vs. Biotech
17:36 - Capital Efficiency and Growth Concerns
18:11 - Maintaining Culture and Focus in a Startup
19:08 - The Challenge of Diverse Disciplines in a Tech Bio Team
20:00 - The Impact of Remote Work on Team Dynamics
21:19 - The Importance of Security and Tools for Remote Work
22:04 - The Benefits of In-Person and Remote Work Balance
22:44 - The Diverse Expertise within the BioCortex Team
00:23:27 - The Future of Tech Bio and Biotech Industry
In this episode of Nothing Ventured, we delve into the world of tech bio
with co-founders Nik Sharma and Mo Alomari from BioCortex. They discuss
reflecting biology in silico, NASA-inspired strategies, and the
importance of trust in co-founder relationships. Learn how BioCortex is
revolutionizing therapeutic development with insights backed by Hoxton
and Sofinova. Tune in for a deep dive into the intersection of
technology and biotech with these innovative minds.
🕒 Time stamps -
01:01 - Introducing Guests Nick Sharma and Mo Al-Omari
01:55 - Emulation vs. Simulation in Tech Bio
02:16 - BioCortex: A Tech Bio Company Overview
02:27 - Founders' Backgrounds and Expertise
03:09 - BioCortex's Vision and Technology
03:33 - Personalizing Medication Efficacy with BioCortex
04:15 - Broader Applications of BioCortex Technology
04:31 - Carbon Knowledge and Carbon Mirror Technologies
05:03 - Emulation in Aerospace Applied to Biology
05:38 - Conceptualizing Human Biology for Drug Interaction
06:25 - Understanding Emulation and Simulation
07:04 - The Role of Bacteria in Drug Efficacy
07:34 - The Distinction Between Emulation and Simulation
08:34 - NASA's Use of Emulation
09:10 - The Importance of Understanding Mechanisms in Medicine
09:43 - The Reality of Drug Response Rates
10:21 - BioCortex's Approach to AI and Emulation
11:01 - The Co-Founders' Meeting and Collaboration
11:29 - The Genesis of BioCortex
12:00 - Addressing Motor Neurone Disease Communication
13:02 - The Evolution of Nick and Mo's Partnership
13:38 - The Challenge of Modeling Bacteria
14:02 - The Solution to Modeling Complex Biological Systems
14:58 - The Importance of Trust in Co-Founder Relationships
16:01 - The Dynamics of Co-Founder and VC Relationships
16:53 - Defining Tech Bio vs. Biotech
17:36 - Capital Efficiency and Growth Concerns
18:11 - Maintaining Culture and Focus in a Startup
19:08 - The Challenge of Diverse Disciplines in a Tech Bio Team
20:00 - The Impact of Remote Work on Team Dynamics
21:19 - The Importance of Security and Tools for Remote Work
22:04 - The Benefits of In-Person and Remote Work Balance
22:44 - The Diverse Expertise within the BioCortex Team
00:23:27 - The Future of Tech Bio and Biotech Industry
28 min